Based on this knowledge, several studies have designed novel treatment strategies using soluble or nanoparticle-displayed ACE2 as receptor decoys [3–5], with the aim of sequestering SARS-CoV-2 particles away from authentic cell-expressed ACE2 and preventing infection. This evidence concerns the gene ACE2 and infection.